Literature DB >> 14757367

Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils.

Elaine Hatanaka1, Cristiane J Furlaneto, Fernanda P Ribeiro, Glaucia Mendes Souza, Ana Campa.   

Abstract

Recently, we described the effect of the acute phase protein serum amyloid A (SAA) on the mRNA expression and release of IL-8 in neutrophils [Mediators Inflamm. 12 (3) (2003) 173]. Here, we expand this earlier study, focusing on tumor necrosis factor-alpha (TNF-alpha) m-RNA expression and protein release. Our findings indicate that SAA stimulates the rapid expression and release of TNF-alpha from cultured human blood neutrophils. The release of TNF-alpha from SAA-stimulated neutrophils is strongly suppressed by the addition of the antioxidants N-acetyl-L-cysteine, alpha-mercaptoethanol, glutathione, the antiinflammatory dexamethasone and the compounds wortmannin (a PI3K inhibitor), PD98059 (a MEK-1 inhibitor) and SB203580 (a p38 inhibitor). Monocytes also responded to SAA by releasing TNF-alpha. These data are congruent with the increasing evidence of the role of SAA in modulating inflammatory and immune responses, possibly contributing to the pool of cytokines produced in acute inflammation and in chronic diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757367     DOI: 10.1016/j.imlet.2003.09.011

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  20 in total

1.  A novel axis of innate immunity in cancer.

Authors:  Stephen R Mattarollo; Mark J Smyth
Journal:  Nat Immunol       Date:  2010-11       Impact factor: 25.606

2.  Serum amyloid A directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Zhe Dong; Tingting Wu; Weidong Qin; Chuankai An; Zhihao Wang; Mingxiang Zhang; Yun Zhang; Cheng Zhang; Fengshuang An
Journal:  Mol Med       Date:  2011-09-21       Impact factor: 6.354

3.  Serum amyloid A induces reactive oxygen species (ROS) production and proliferation of fibroblast.

Authors:  E Hatanaka; A Dermargos; H A Armelin; R Curi; A Campa
Journal:  Clin Exp Immunol       Date:  2010-12-22       Impact factor: 4.330

4.  Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes.

Authors:  E Hatanaka; P T Monteagudo; M S M Marrocos; A Campa
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

5.  A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A.

Authors:  Ronan Hugh Mullan; Jennifer McCormick; Mary Connolly; Barry Bresnihan; Douglas James Veale; Ursula Fearon
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

Review 6.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 7.  The cytokine-serum amyloid A-chemokine network.

Authors:  Mieke De Buck; Mieke Gouwy; Ji Ming Wang; Jacques Van Snick; Paul Proost; Sofie Struyf; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2015-12-28       Impact factor: 7.638

8.  Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance.

Authors:  F B Filippin-Monteiro; E M de Oliveira; S Sandri; F H Knebel; R C Albuquerque; A Campa
Journal:  Int J Obes (Lond)       Date:  2011-10-11       Impact factor: 5.095

9.  Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors.

Authors:  Karin Christenson; Lena Björkman; Sofie Ahlin; Maja Olsson; Kajsa Sjöholm; Anna Karlsson; Johan Bylund
Journal:  Front Immunol       Date:  2013-04-22       Impact factor: 7.561

10.  Acute phase response to exertional heat stroke in mice.

Authors:  John Iwaniec; Gerard P Robinson; Christian K Garcia; Kevin O Murray; Lucas de Carvalho; Thomas L Clanton; Orlando Laitano
Journal:  Exp Physiol       Date:  2020-05-12       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.